Exact Mass: 431.19131860000005
Exact Mass Matches: 431.19131860000005
Found 176 metabolites which its exact mass value is equals to given mass value 431.19131860000005
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Glenvastatin
C27H26FNO3 (431.18966180000007)
D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents D004791 - Enzyme Inhibitors > D019161 - Hydroxymethylglutaryl-CoA Reductase Inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent C471 - Enzyme Inhibitor > C1655 - HMG-CoA Reductase Inhibitor D009676 - Noxae > D000963 - Antimetabolites
DTXSID10996162
C23H36Cl3N (431.19131860000005)
Fusarin C
Fusarin C is produced by many Fusarium species in infected corn. Production by many Fusarium subspecies in infected corn. D009676 - Noxae > D009153 - Mutagens
Lafutidine
C22H29N3O4S (431.1878674000001)
Lafutidine is a histamine H2-receptor antagonist that inhibits histamine-stimulated gastric acid secretion. Due to the resulting reduction in gastric volume and acidity, lafutidine can be used to treat ulcers and reflux. A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) > A02BA - H2-receptor antagonists C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29702 - Histamine-2 Receptor Antagonist D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents Lafutidine (FRG-8813) is a histamine H2-receptor antagonist (H2RA), with proven gastric mucosal protective effects. Lafutidine can be used for the research of gastroesophageal reflux disease[1].
(3S,11R,11aR)-3-Methoxy-4,9-dimethyl-8beta-hydroxy-3beta-[[(2S,4S)-4-methyl-5-oxotetrahydrofuran]-2-yl]-2,3,5,6,7,8-hexahydrospiro[1H-cyclopenta[b]pyrrolo[1,2-a]azepine-11(10H),2(5H)-furan]-5,10-dione
4-methoxy-3-methyl-5-[(2Z,3aR)-3ac,10c-epoxy-1t-methyl-8t-((2S)-4c-methyl-5-oxo-tetrahydrofuran-2r-yl)-(3ar,10at,10bt)-decahydro-2H-furo[3,2-c]pyrrolo[1,2-a]azepin-2-ylidene]-5H-furan-2-one|oxyprotostemonine
Lafutidine
C22H29N3O4S (431.1878674000001)
A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) > A02BA - H2-receptor antagonists C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29702 - Histamine-2 Receptor Antagonist D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents Lafutidine (FRG-8813) is a histamine H2-receptor antagonist (H2RA), with proven gastric mucosal protective effects. Lafutidine can be used for the research of gastroesophageal reflux disease[1].
Ala Met Asn Pro
C17H29N5O6S (431.18384540000005)
Ala Met Pro Asn
C17H29N5O6S (431.18384540000005)
Ala Asn Met Pro
C17H29N5O6S (431.18384540000005)
Ala Asn Pro Met
C17H29N5O6S (431.18384540000005)
Ala Pro Met Asn
C17H29N5O6S (431.18384540000005)
Ala Pro Asn Met
C17H29N5O6S (431.18384540000005)
Cys Gly Pro Arg
C16H29N7O5S (431.19507840000006)
Cys Gly Arg Pro
C16H29N7O5S (431.19507840000006)
Cys Asn Pro Val
C17H29N5O6S (431.18384540000005)
Cys Asn Val Pro
C17H29N5O6S (431.18384540000005)
Cys Pro Gly Arg
C16H29N7O5S (431.19507840000006)
Cys Pro Asn Val
C17H29N5O6S (431.18384540000005)
Cys Pro Arg Gly
C16H29N7O5S (431.19507840000006)
Cys Pro Val Asn
C17H29N5O6S (431.18384540000005)
Cys Arg Gly Pro
C16H29N7O5S (431.19507840000006)
Cys Arg Pro Gly
C16H29N7O5S (431.19507840000006)
Cys Val Asn Pro
C17H29N5O6S (431.18384540000005)
Cys Val Pro Asn
C17H29N5O6S (431.18384540000005)
Gly Cys Pro Arg
C16H29N7O5S (431.19507840000006)
Gly Cys Arg Pro
C16H29N7O5S (431.19507840000006)
Gly Met Pro Gln
C17H29N5O6S (431.18384540000005)
Gly Met Gln Pro
C17H29N5O6S (431.18384540000005)
Gly Pro Cys Arg
C16H29N7O5S (431.19507840000006)
Gly Pro Met Gln
C17H29N5O6S (431.18384540000005)
Gly Pro Gln Met
C17H29N5O6S (431.18384540000005)
Gly Pro Arg Cys
C16H29N7O5S (431.19507840000006)
Gly Gln Met Pro
C17H29N5O6S (431.18384540000005)
Gly Gln Pro Met
C17H29N5O6S (431.18384540000005)
Gly Arg Cys Pro
C16H29N7O5S (431.19507840000006)
Gly Arg Pro Cys
C16H29N7O5S (431.19507840000006)
Met Ala Asn Pro
C17H29N5O6S (431.18384540000005)
Met Ala Pro Asn
C17H29N5O6S (431.18384540000005)
Met Gly Pro Gln
C17H29N5O6S (431.18384540000005)
Met Gly Gln Pro
C17H29N5O6S (431.18384540000005)
Met Asn Ala Pro
C17H29N5O6S (431.18384540000005)
Met Asn Pro Ala
C17H29N5O6S (431.18384540000005)
Met Pro Ala Asn
C17H29N5O6S (431.18384540000005)
Met Pro Gly Gln
C17H29N5O6S (431.18384540000005)
Met Pro Asn Ala
C17H29N5O6S (431.18384540000005)
Met Pro Gln Gly
C17H29N5O6S (431.18384540000005)
Met Gln Gly Pro
C17H29N5O6S (431.18384540000005)
Met Gln Pro Gly
C17H29N5O6S (431.18384540000005)
Asn Ala Met Pro
C17H29N5O6S (431.18384540000005)
Asn Ala Pro Met
C17H29N5O6S (431.18384540000005)
Asn Cys Pro Val
C17H29N5O6S (431.18384540000005)
Asn Cys Val Pro
C17H29N5O6S (431.18384540000005)
Asn Met Ala Pro
C17H29N5O6S (431.18384540000005)
Asn Met Pro Ala
C17H29N5O6S (431.18384540000005)
Asn Pro Ala Met
C17H29N5O6S (431.18384540000005)
Asn Pro Cys Val
C17H29N5O6S (431.18384540000005)
Asn Pro Met Ala
C17H29N5O6S (431.18384540000005)
Asn Pro Val Cys
C17H29N5O6S (431.18384540000005)
Asn Val Cys Pro
C17H29N5O6S (431.18384540000005)
Asn Val Pro Cys
C17H29N5O6S (431.18384540000005)
Pro Ala Met Asn
C17H29N5O6S (431.18384540000005)
Pro Ala Asn Met
C17H29N5O6S (431.18384540000005)
Pro Cys Gly Arg
C16H29N7O5S (431.19507840000006)
Pro Cys Asn Val
C17H29N5O6S (431.18384540000005)
Pro Cys Arg Gly
C16H29N7O5S (431.19507840000006)
Pro Cys Val Asn
C17H29N5O6S (431.18384540000005)
Pro Gly Cys Arg
C16H29N7O5S (431.19507840000006)
Pro Gly Met Gln
C17H29N5O6S (431.18384540000005)
Pro Gly Gln Met
C17H29N5O6S (431.18384540000005)
Pro Gly Arg Cys
C16H29N7O5S (431.19507840000006)
Pro Met Ala Asn
C17H29N5O6S (431.18384540000005)
Pro Met Gly Gln
C17H29N5O6S (431.18384540000005)
Pro Met Asn Ala
C17H29N5O6S (431.18384540000005)
Pro Met Gln Gly
C17H29N5O6S (431.18384540000005)
Pro Asn Ala Met
C17H29N5O6S (431.18384540000005)
Pro Asn Cys Val
C17H29N5O6S (431.18384540000005)
Pro Asn Met Ala
C17H29N5O6S (431.18384540000005)
Pro Asn Val Cys
C17H29N5O6S (431.18384540000005)
Pro Gln Gly Met
C17H29N5O6S (431.18384540000005)
Pro Gln Met Gly
C17H29N5O6S (431.18384540000005)
Pro Arg Cys Gly
C16H29N7O5S (431.19507840000006)
Pro Arg Gly Cys
C16H29N7O5S (431.19507840000006)
Pro Val Cys Asn
C17H29N5O6S (431.18384540000005)
Pro Val Asn Cys
C17H29N5O6S (431.18384540000005)
Gln Gly Met Pro
C17H29N5O6S (431.18384540000005)
Gln Gly Pro Met
C17H29N5O6S (431.18384540000005)
Gln Met Gly Pro
C17H29N5O6S (431.18384540000005)
Gln Met Pro Gly
C17H29N5O6S (431.18384540000005)
Gln Pro Gly Met
C17H29N5O6S (431.18384540000005)
Gln Pro Met Gly
C17H29N5O6S (431.18384540000005)
Arg Cys Gly Pro
C16H29N7O5S (431.19507840000006)
Arg Cys Pro Gly
C16H29N7O5S (431.19507840000006)
Arg Gly Cys Pro
C16H29N7O5S (431.19507840000006)
Arg Gly Pro Cys
C16H29N7O5S (431.19507840000006)
Arg Pro Cys Gly
C16H29N7O5S (431.19507840000006)
Arg Pro Gly Cys
C16H29N7O5S (431.19507840000006)
Val Cys Asn Pro
C17H29N5O6S (431.18384540000005)
Val Cys Pro Asn
C17H29N5O6S (431.18384540000005)
Val Asn Cys Pro
C17H29N5O6S (431.18384540000005)
Val Asn Pro Cys
C17H29N5O6S (431.18384540000005)
Val Pro Cys Asn
C17H29N5O6S (431.18384540000005)
Val Pro Asn Cys
C17H29N5O6S (431.18384540000005)
Dinor PGE2 Taurine
C20H33NO7S (431.1977628000001)
Quinagolide hydrochloride
C20H34ClN3O3S (431.20092840000007)
D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists Quinagolide hydrochloride (CV205-502 hydrochloride) is a selective and orally active dopamine D2 receptor agonist. Quinagolide hydrochloride is an inhibitor of prolactin. Quinagolide hydrochloride down-regulates AKT levels and its phosphorylation. Quinagolide hydrochloride shows antitumor effects, it can be used for the research of cancer[1][2]. Quinagolide hydrochloride (CV205-502 hydrochloride) is a selective and orally active dopamine D2 receptor agonist. Quinagolide hydrochloride is an inhibitor of prolactin. Quinagolide hydrochloride down-regulates AKT levels and its phosphorylation. Quinagolide hydrochloride shows antitumor effects, it can be used for the research of cancer[1][2].
Ethaverine hydrochloride
C24H30ClNO4 (431.18632500000007)
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids C471 - Enzyme Inhibitor > C667 - Monoamine Oxidase Inhibitor C93038 - Cation Channel Blocker
Succinimidyl (2R)-6-(Tetrahydro-2H-pyran-2-yloxy)-2,5,7,8-tetramethylchroman-2-carboxylate
sodium,1-dodecoxy-4-(2-hydroxyethylamino)-1,4-dioxobutane-2-sulfonate
C18H34NNaO7S (431.19535740000003)
2-Methyl-3-[4-(3-pyrrolidin-1-ylpropoxy)phenyl]-5-(trifluoromethyl)quinazolin-4-one
Esreboxetine succinate
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C185721 - Norepinephrine Reuptake Inhibitor C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent
1-benzyl-N-(2-morpholinoethyl)-4-oxo-1,4-dihydropyrido[1,2-a]pyrrolo[2,3-d]pyrimidine-2-carboxamide
(5Z)-4-methoxy-3-methyl-5-[(1R,6S,8R,9R,10R,11S)-11-methyl-6-[(2S,4S)-4-methyl-5-oxooxolan-2-yl]-13,14-dioxa-5-azatetracyclo[6.5.1.01,10.05,9]tetradecan-12-ylidene]furan-2-one
3-Furanyl-[4-[2-(3-methoxyphenyl)-5,6-dimethyl-7-pyrazolo[1,5-a]pyrimidinyl]-1-piperazinyl]methanone
1-Methyl-6-[(4-methyl-1-piperidinyl)sulfonyl]-3-[oxo(1-piperidinyl)methyl]-4-quinolinone
C22H29N3O4S (431.1878674000001)
3-Furanyl-[4-[2-(4-methoxyphenyl)-5,6-dimethyl-7-pyrazolo[1,5-a]pyrimidinyl]-1-piperazinyl]methanone
1-methyl-N-(2-methylcyclohexyl)-4-oxo-6-(1-pyrrolidinylsulfonyl)-3-quinolinecarboxamide
C22H29N3O4S (431.1878674000001)
N-[4-(diethylsulfamoyl)phenyl]-4-(4-morpholinylmethyl)benzamide
C22H29N3O4S (431.1878674000001)
(4-Methylphenyl)-[4-[4-nitro-3-(3-pyridinylmethylamino)phenyl]-1-piperazinyl]methanone
(E)-3-[2-(azepan-1-yl)-9-methyl-4-oxopyrido[1,2-a]pyrimidin-3-yl]-2-cyano-N-(furan-2-ylmethyl)prop-2-enamide
(3R)-2-acetyl-N-ethyl-3-(2-hydroxyethyl)-4-[3-(5-pyrimidinyl)phenyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
(3S)-2-acetyl-N-ethyl-3-(2-hydroxyethyl)-4-[3-(5-pyrimidinyl)phenyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
N-[(4-chlorophenyl)methyl]-2-[(3S,5Z,8S,12S)-8-methyl-2,9-dioxo-1,10-diazabicyclo[10.3.0]pentadec-5-en-3-yl]acetamide
C23H30ClN3O3 (431.1975580000001)
(2R,3R,3aS,9bS)-3-(hydroxymethyl)-6-oxo-7-phenyl-1-(2-pyridinylmethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylic acid methyl ester
1-[(3aS,4R,9bR)-8-(2-fluorophenyl)-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-2-(2-pyridinyl)ethanone
1-[(3aS,4R,9bR)-8-(3-fluorophenyl)-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-2-(3-pyridinyl)ethanone
1-[(3aR,4S,9bS)-8-(3-fluorophenyl)-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-2-(3-pyridinyl)ethanone
(2S,3S,3aR,9bR)-3-(hydroxymethyl)-6-oxo-7-phenyl-1-(2-pyridinylmethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylic acid methyl ester
1-[(3aR,4R,9bS)-8-(2-fluorophenyl)-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-2-(2-pyridinyl)ethanone
1-[(3aR,4R,9bS)-8-(3-fluorophenyl)-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-2-(3-pyridinyl)ethanone
1-[(3aS,4S,9bR)-8-(3-fluorophenyl)-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-2-(3-pyridinyl)ethanone
3beta-Chloro-N,N-bis(2-chloroethyl)-androst-5-en-17beta-amine
C23H36Cl3N (431.19131860000005)
(2s,3r)-2-[(2e,4e,6e,8e,10e)-10-ethylidene-11-methoxy-2,6,8-trimethyl-11-oxoundeca-2,4,6,8-tetraenoyl]-3-(3-hydroxypropanoyl)oxirane-2-carboximidic acid
methyl (7e,9e)-11-[2,4-dihydroxy-4-(2-hydroxyethyl)-6-oxa-3-azabicyclo[3.1.0]hex-2-en-1-yl]-2-ethylidene-4,6,10-trimethyl-11-oxoundeca-3,5,7,9-tetraenoate
(1's,2r,2's,3's,6'r)-3'-ethyl-1'-methoxy-4-methyl-11'-[(2s,4s)-4-methyl-5-oxooxolan-2-yl]-5'-oxa-10'-azaspiro[furan-2,4'-tricyclo[8.3.0.0²,⁶]tridecan]-11'-ene-5,13'-dione
4-methoxy-3-methyl-5-[(1r,3e,4s,5r,6s,8s,9s)-4-methyl-9-[(2s,4s)-4-methyl-5-oxooxolan-2-yl]-2,14-dioxa-10-azatetracyclo[6.5.1.0¹,⁵.0⁶,¹⁰]tetradecan-3-ylidene]furan-2-one
methyl (2e,3e,5e,7e,9e)-11-[(1s,4s,5r)-2,4-dihydroxy-4-(2-hydroxyethyl)-6-oxa-3-azabicyclo[3.1.0]hex-2-en-1-yl]-2-ethylidene-4,6,10-trimethyl-11-oxoundeca-3,5,7,9-tetraenoate
methyl 11-[3,4-dihydroxy-1-(2-hydroxyethyl)-6-oxa-2-azabicyclo[3.1.0]hex-2-en-4-yl]-2-ethylidene-4,6,10-trimethyl-11-oxoundeca-3,5,7,9-tetraenoate
methyl (9e)-11-[2,4-dihydroxy-4-(2-hydroxyethyl)-6-oxa-3-azabicyclo[3.1.0]hex-2-en-1-yl]-2-ethylidene-4,6,10-trimethyl-11-oxoundeca-3,5,7,9-tetraenoate
(1r,9r,12s,13s)-12-(acetyloxy)-3-hydroxy-4,11-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,10-tetraen-13-yl acetate
(2e,6e)-8-{2-[(1s)-1-carboxy-2-methylpropyl]-4,6-dihydroxy-1-oxo-3h-isoindol-5-yl}-2,6-dimethylocta-2,6-dienoic acid
methyl (2e,3e,5e,7e,9e)-11-[(1s,4s,5s)-3,4-dihydroxy-1-(2-hydroxyethyl)-6-oxa-2-azabicyclo[3.1.0]hex-2-en-4-yl]-2-ethylidene-4,6,10-trimethyl-11-oxoundeca-3,5,7,9-tetraenoate
methyl (2e,3e,5z,7e,9e)-11-[(1s,4s,5r)-2,4-dihydroxy-4-(2-hydroxyethyl)-6-oxa-3-azabicyclo[3.1.0]hex-2-en-1-yl]-2-ethylidene-4,6,10-trimethyl-11-oxoundeca-3,5,7,9-tetraenoate
5-{2,5-dihydroxy-7-oxabicyclo[4.1.0]heptan-2-yl}-1,2-dihydroxy-3-(2-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl)pyridin-4-one
(2s,10s,12r)-13-hydroxy-10-(2-methylbut-3-en-2-yl)-21-oxo-1,3,14-triazapentacyclo[10.9.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-4,6,8,13,15,17,19-heptaen-3-yl acetate
3-[(1r,2s,4ar,8ar)-2-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-5-{2,5-dihydroxy-7-oxabicyclo[4.1.0]heptan-2-yl}-1,4-dihydroxypyridin-2-one
13-hydroxy-10-(2-methylbut-3-en-2-yl)-21-oxo-1,3,14-triazapentacyclo[10.9.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-4,6,8,13,15,17,19-heptaen-3-yl acetate
4-methoxy-3-methyl-5-[(1r,3z,4s,5r,6s,8s,9s)-4-methyl-9-[(2s,4s)-4-methyl-5-oxooxolan-2-yl]-2,14-dioxa-10-azatetracyclo[6.5.1.0¹,⁵.0⁶,¹⁰]tetradecan-3-ylidene]furan-2-one
(1s,9s,12s,13s)-12-(acetyloxy)-3-hydroxy-4,11-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,10-tetraen-13-yl acetate
methyl 2-(dimethylamino)-3-hydroxy-14-oxo-4,10-bis(prop-1-en-2-yl)-13,15,16-trioxatetracyclo[9.2.2.1⁵,⁸.0¹,¹²]hexadeca-5,7-diene-7-carboxylate
4-methoxy-3-methyl-5-[(12e)-11-methyl-6-(4-methyl-5-oxooxolan-2-yl)-13,14-dioxa-5-azatetracyclo[6.5.1.0¹,¹⁰.0⁵,⁹]tetradecan-12-ylidene]furan-2-one
8-[2-(1-carboxy-2-methylpropyl)-4,6-dihydroxy-1-oxo-3h-isoindol-5-yl]-2,6-dimethylocta-2,6-dienoic acid
methyl 11-[2,4-dihydroxy-4-(2-hydroxyethyl)-6-oxa-3-azabicyclo[3.1.0]hex-2-en-1-yl]-2-ethylidene-4,6,10-trimethyl-11-oxoundeca-3,5,7,9-tetraenoate
2-(10-ethylidene-11-methoxy-2,6,8-trimethyl-11-oxoundeca-2,4,6,8-tetraenoyl)-3-(3-hydroxypropanoyl)oxirane-2-carboximidic acid
5-{2,5-dihydroxy-7-oxabicyclo[4.1.0]heptan-2-yl}-1,4-dihydroxy-3-(2-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl)pyridin-2-one
(2s,10r,12s)-3-acetyl-12,13-dihydroxy-10-(2-methylbut-3-en-2-yl)-1,3,14-triazapentacyclo[10.9.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-4,6,8,13,15,17,19-heptaen-21-one
2-[(1s)-1-carboxy-2-(1h-indol-3-yl)ethyl]-5-hydroxy-5,7,7-trimethyl-9-oxo-5ah,6h-cyclopenta[g]isoquinolin-2-ium
[C26H27N2O4]+ (431.19707220000004)